Literature DB >> 6446943

Another look at the Sparks-Mandril arterial graft precursor for vascular repair. - Pathology by scanning electron microscopy.

R Guidoin, H P Noël, M Marois, L Martin, F Laroche, L Béland, R Côté, C Gosselin, J Descotes, E Chignier, P Blais.   

Abstract

The Sparks-Mandril blood vessel precursor system, an autogenous tissue growth-promoting device, in spite of its ingenuity and its surgical elegance, has received only limited usage. At technique for peripheral blood vessels by several authors. In the latter period, this laboratory also undertook similar work. The results of seven implantations in dogs and two in patients are reported here in the context of a program on the evaluation of blood vessel substitutes, their mode of operation and their long term performance. The clinical status and the pathology of the grafts at time of failure were investigated using techniques of scanning electron microscopy. This work confirms the findings of other centres regarding the generally unsatisfactory performance of the Sparks-Mandril system. Possible causes for failure in mandril-formed blood vessels are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6446943     DOI: 10.3109/10731198009118977

Source DB:  PubMed          Journal:  Biomater Med Devices Artif Organs        ISSN: 0090-5488


  3 in total

1.  Early results of a reinforced biosynthetic ovine collagen vascular prosthesis for small arterial reconstruction.

Authors:  H Yoshida; T Sasajima; K Goh; M Inaba; N Otani; Y Kubo
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

2.  Fast optical transillumination tomography with large-size projection acquisition.

Authors:  Hsuan-Ming Huang; Jinjun Xia; Mark A Haidekker
Journal:  Ann Biomed Eng       Date:  2008-08-14       Impact factor: 3.934

Review 3.  Quickening: Translational design of resorbable synthetic vascular grafts.

Authors:  Chelsea E T Stowell; Yadong Wang
Journal:  Biomaterials       Date:  2018-05-05       Impact factor: 12.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.